<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Pick Disease - Disorder Mechanisms</title>
    <style>
        :root {
            --primary: #0f766e;
            --primary-light: #14b8a6;
            --primary-dark: #0d5c56;
            --secondary: #6366f1;
            --bg: #f0fdfa;
            --card-bg: #ffffff;
            --text: #134e4a;
            --text-muted: #5f7a78;
            --border: #ccfbf1;
            --accent-orange: #f59e0b;
            --accent-rose: #f43f5e;
            --accent-violet: #8b5cf6;
            --accent-sky: #0ea5e9;
        }

        * { box-sizing: border-box; margin: 0; padding: 0; }

        body {
            font-family: 'Segoe UI', system-ui, -apple-system, sans-serif;
            background: var(--bg);
            color: var(--text);
            line-height: 1.7;
        }

        .container {
            max-width: 1100px;
            margin: 0 auto;
            padding: 24px;
        }

        /* Header */
        .page-header {
            background: linear-gradient(135deg, var(--primary) 0%, var(--primary-dark) 100%);
            color: white;
            padding: 40px 32px;
            border-radius: 16px;
            margin-bottom: 24px;
            position: relative;
            overflow: hidden;
        }

        .page-header::before {
            content: '';
            position: absolute;
            top: -50%;
            right: -20%;
            width: 400px;
            height: 400px;
            background: rgba(255,255,255,0.05);
            border-radius: 50%;
        }

        .page-header h1 {
            font-size: 2.2rem;
            font-weight: 700;
            margin-bottom: 12px;
            position: relative;
        }

        .header-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 12px;
            align-items: center;
            position: relative;
        }

        .badge {
            display: inline-flex;
            align-items: center;
            padding: 6px 14px;
            border-radius: 20px;
            font-size: 0.85rem;
            font-weight: 500;
        }

        .badge-category {
            background: rgba(255,255,255,0.2);
            color: white;
        }

        .badge-mondo {
            background: var(--accent-sky);
            color: white;
        }

        .badge-mondo a {
            color: inherit;
            text-decoration: none;
        }

        .badge-mondo a:hover {
            text-decoration: underline;
        }

        /* Navigation */
        .breadcrumb {
            margin-bottom: 16px;
            font-size: 0.9rem;
        }

        .breadcrumb a {
            color: var(--primary);
            text-decoration: none;
        }

        .breadcrumb a:hover {
            text-decoration: underline;
        }

        .breadcrumb span {
            color: var(--text-muted);
        }

        /* Cards */
        .card {
            background: var(--card-bg);
            border-radius: 12px;
            border: 1px solid var(--border);
            padding: 24px;
            margin-bottom: 20px;
            box-shadow: 0 1px 3px rgba(0,0,0,0.04);
        }

        .card-header {
            display: flex;
            align-items: center;
            gap: 12px;
            margin-bottom: 16px;
            padding-bottom: 12px;
            border-bottom: 2px solid var(--border);
        }

        .card-icon {
            width: 36px;
            height: 36px;
            border-radius: 8px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 1.2rem;
        }

        .card-title {
            font-size: 1.1rem;
            font-weight: 600;
            color: var(--text);
        }

        .card-count {
            margin-left: auto;
            background: var(--bg);
            padding: 4px 12px;
            border-radius: 12px;
            font-size: 0.8rem;
            color: var(--text-muted);
        }

        /* Sections */
        .section-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(320px, 1fr));
            gap: 20px;
        }

        /* Tags */
        .tag-list {
            display: flex;
            flex-wrap: wrap;
            gap: 8px;
        }

        .tag {
            padding: 6px 12px;
            border-radius: 6px;
            font-size: 0.85rem;
            font-weight: 500;
        }

        .tag-cell {
            background: #fce7f3;
            color: #9d174d;
        }

        .tag-gene {
            background: #dbeafe;
            color: #1e40af;
        }

        .tag-treatment {
            background: #ede9fe;
            color: #5b21b6;
        }

        .tag-env {
            background: #ccfbf1;
            color: #0f766e;
        }

        .tag-bio {
            background: #fef3c7;
            color: #92400e;
        }

        .tag-modifier {
            background: #fee2e2;
            color: #991b1b;
            text-transform: uppercase;
            letter-spacing: 0.02em;
        }

        .tag-parent {
            background: #e0e7ff;
            color: #3730a3;
        }

        .tag-classification {
            background: #fef3c7;
            color: #92400e;
        }

        .tag-mechanistic {
            background: #dbeafe;
            color: #1e40af;
        }

        .linkout {
            color: inherit;
            margin-left: 6px;
            font-size: 0.75rem;
            text-decoration: none;
            border-bottom: 1px dotted rgba(0, 0, 0, 0.2);
        }

        .classification-category {
            font-size: 0.75rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.05em;
            color: var(--text-muted);
            margin-bottom: 8px;
        }

        /* Evidence styling */
        .evidence-toggle {
            cursor: pointer;
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-top: 10px;
            user-select: none;
        }

        .evidence-toggle:hover {
            color: var(--primary);
        }

        .evidence-list {
            margin-top: 10px;
            padding-left: 0;
        }

        .evidence-item {
            padding: 12px 14px;
            background: #f8fafc;
            border-radius: 8px;
            margin-bottom: 8px;
            border: 1px solid #e2e8f0;
            font-size: 0.9rem;
        }

        .evidence-header {
            display: flex;
            align-items: center;
            flex-wrap: wrap;
            gap: 8px;
        }

        .evidence-ref {
            font-weight: 600;
            color: var(--secondary);
        }

        .evidence-ref a {
            color: inherit;
            text-decoration: none;
        }

        .evidence-ref a:hover {
            text-decoration: underline;
        }

        .evidence-support {
            font-size: 0.7rem;
            padding: 2px 8px;
            border-radius: 4px;
            font-weight: 600;
            text-transform: uppercase;
            transition: transform 120ms ease, box-shadow 120ms ease;
        }

        .support-SUPPORT { background: #dcfce7; color: #166534; }
        .support-PARTIAL { background: #fef3c7; color: #92400e; }
        .support-REFUTE { background: #fee2e2; color: #991b1b; }
        .support-NO_EVIDENCE { background: #f1f5f9; color: #64748b; }
        .support-WRONG_STATEMENT { background: #fecaca; color: #7f1d1d; }

        .evidence-source {
            font-size: 0.7rem;
            padding: 2px 8px;
            border-radius: 4px;
            font-weight: 600;
            text-transform: uppercase;
            background: #e2e8f0;
            color: #334155;
            transition: transform 120ms ease, box-shadow 120ms ease;
        }

        .evidence-support:hover,
        .evidence-source:hover {
            transform: translateY(-1px);
            box-shadow: 0 4px 10px rgba(0,0,0,0.08);
        }

        .source-HUMAN_CLINICAL { background: #e0f2fe; color: #075985; }
        .source-MODEL_ORGANISM { background: #fef9c3; color: #854d0e; }
        .source-IN_VITRO { background: #ede9fe; color: #5b21b6; }
        .source-COMPUTATIONAL { background: #cffafe; color: #0e7490; }
        .source-OTHER { background: #e5e7eb; color: #374151; }

        .evidence-snippet {
            font-size: 0.85rem;
            color: var(--text-muted);
            margin-top: 8px;
            padding-left: 12px;
            border-left: 2px solid #cbd5e1;
            font-style: italic;
            line-height: 1.5;
        }

        .evidence-explanation {
            font-size: 0.85rem;
            color: var(--text);
            margin-top: 6px;
            line-height: 1.5;
        }

        .evidence-more {
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-top: 6px;
            font-style: italic;
        }

        /* Item containers with evidence */
        .item-box {
            padding: 16px;
            border-radius: 10px;
            margin-bottom: 12px;
        }

        .item-name {
            font-weight: 600;
            margin-bottom: 6px;
        }

        .item-desc {
            font-size: 0.9rem;
            line-height: 1.6;
            margin-bottom: 8px;
        }

        .item-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 6px;
            margin-top: 8px;
        }

        /* Pathophysiology */
        .pathophys-box {
            background: linear-gradient(135deg, #fef3c7 0%, #fef9c3 100%);
            border-left: 4px solid var(--accent-orange);
        }
        .pathophys-box .item-name { color: #92400e; }
        .pathophys-box .item-desc { color: #78350f; }

        /* Histopathology */
        .histopathology-box {
            background: #fff7ed;
            border-left: 4px solid #fb923c;
        }
        .histopathology-box .item-name { color: #9a3412; }
        .histopathology-box .item-desc { color: #c2410c; }

        .histopathology-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #ffedd5;
            color: #c2410c;
        }

        /* Phenotypes */
        .phenotype-box {
            background: #f0fdf4;
            border-left: 4px solid #22c55e;
        }
        .phenotype-box .item-name { color: #166534; }
        .phenotype-box .item-desc { color: #15803d; }

        .phenotype-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #dcfce7;
            color: #15803d;
        }

        .phenotype-category {
            font-size: 0.75rem;
            color: #4ade80;
        }

        .phenotype-id a {
            font-size: 0.8rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .phenotype-id a:hover {
            text-decoration: underline;
        }

        /* Genetic */
        .genetic-box {
            background: #eff6ff;
            border-left: 4px solid #3b82f6;
        }
        .genetic-box .item-name { color: #1e40af; }
        .genetic-box .item-desc { color: #2563eb; }

        /* Treatment */
        .treatment-box {
            background: #faf5ff;
            border-left: 4px solid #8b5cf6;
        }
        .treatment-box .item-name { color: #5b21b6; }
        .treatment-box .item-desc { color: #7c3aed; }

        /* Environmental */
        .environmental-box {
            background: #f0fdfa;
            border-left: 4px solid #14b8a6;
        }
        .environmental-box .item-name { color: #0f766e; }
        .environmental-box .item-desc { color: #0d9488; }

        /* Biochemical */
        .biochemical-box {
            background: #fffbeb;
            border-left: 4px solid #f59e0b;
        }
        .biochemical-box .item-name { color: #92400e; }
        .biochemical-box .item-desc { color: #b45309; }

        /* Differential Diagnoses */
        .differential-box {
            background: #fef2f2;
            border-left: 4px solid #dc2626;
        }
        .differential-box .item-name { color: #7f1d1d; }
        .differential-box .item-desc { color: #b91c1c; }

        .differential-similarities {
            background: #fee2e2;
            border-left: 2px solid #dc2626;
            padding: 10px 12px;
            border-radius: 6px;
            margin: 8px 0;
            font-size: 0.9rem;
        }

        .differential-distinctions {
            background: #dcfce7;
            border-left: 2px solid #16a34a;
            padding: 10px 12px;
            border-radius: 6px;
            margin: 8px 0;
            font-size: 0.9rem;
        }

        .differential-similarities strong,
        .differential-distinctions strong {
            display: block;
            margin-bottom: 6px;
            font-size: 0.85rem;
            text-transform: uppercase;
            letter-spacing: 0.05em;
        }

        .differential-similarities ul,
        .differential-distinctions ul {
            margin-left: 16px;
            line-height: 1.6;
        }

        .differential-similarities li,
        .differential-distinctions li {
            margin: 4px 0;
            font-size: 0.9rem;
        }

        /* Datasets */
        .dataset-box {
            background: #f0f9ff;
            border-left: 4px solid #0284c7;
        }
        .dataset-box .item-name { color: #0c4a6e; }
        .dataset-box .item-desc { color: #0369a1; }

        .tag-dataset {
            background: #e0f2fe;
            color: #0369a1;
        }

        .tag-organism {
            background: #fae8ff;
            color: #a21caf;
        }

        .tag-datatype {
            background: #dbeafe;
            color: #1d4ed8;
        }

        /* Clinical Trials */
        .clinical-trial-box {
            background: #f5f3ff;
            border-left: 4px solid #a855f7;
        }
        .clinical-trial-box .item-name { color: #6b21a8; }
        .clinical-trial-box .item-desc { color: #7e22ce; }

        .tag-phase {
            background: #ede9fe;
            color: #6b21a8;
        }

        .tag-status {
            background: #fce7f3;
            color: #9d174d;
        }

        .trial-nct a {
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .trial-nct a:hover {
            text-decoration: underline;
        }

        .dataset-accession a {
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .dataset-accession a:hover {
            text-decoration: underline;
        }

        /* Subtypes */
        .subtype-box {
            background: #eef2ff;
            border-left: 4px solid var(--secondary);
        }
        .subtype-box .item-name { color: #3730a3; }
        .subtype-box .item-desc { color: #4f46e5; }

        /* Stats bar */
        .stats-bar {
            display: flex;
            gap: 24px;
            padding: 20px 24px;
            background: var(--card-bg);
            border-radius: 12px;
            border: 1px solid var(--border);
            margin-bottom: 24px;
            flex-wrap: wrap;
        }

        .stat-item {
            text-align: center;
        }

        .stat-value {
            font-size: 1.5rem;
            font-weight: 700;
            color: var(--primary);
        }

        .stat-label {
            font-size: 0.8rem;
            color: var(--text-muted);
            text-transform: uppercase;
            letter-spacing: 0.05em;
        }

        /* YAML preview */
        .yaml-preview {
            background: #1e293b;
            color: #e2e8f0;
            padding: 20px;
            border-radius: 8px;
            overflow-x: auto;
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            line-height: 1.5;
            max-height: 400px;
            overflow-y: auto;
        }

        .yaml-content {
            display: none;
        }

        .yaml-content.show {
            display: block;
        }

        /* Footer */
        .page-footer {
            margin-top: 40px;
            padding-top: 20px;
            border-top: 1px solid var(--border);
            text-align: center;
            color: var(--text-muted);
            font-size: 0.85rem;
        }

        .page-footer a {
            color: var(--primary);
            text-decoration: none;
        }

        .page-footer a:hover {
            text-decoration: underline;
        }

        /* Responsive */
        @media (max-width: 768px) {
            .page-header h1 { font-size: 1.6rem; }
            .stats-bar { gap: 16px; }
            .section-grid { grid-template-columns: 1fr; }
        }
        /* Mermaid graph */
        .mermaid-container {
            text-align: center;
            margin: 20px 0;
            padding: 20px;
            background: white;
            border-radius: 8px;
            border: 1px solid var(--border);
            overflow-x: auto;
        }

        .mermaid svg {
            max-width: 100%;
            height: auto;
        }

        .graph-warning {
            background: #fef3c7;
            border: 1px solid #f59e0b;
            border-radius: 8px;
            padding: 12px 16px;
            margin-bottom: 16px;
            font-size: 0.85rem;
            color: #92400e;
        }

        .graph-warning strong {
            display: block;
            margin-bottom: 4px;
        }

        .graph-warning ul {
            margin: 8px 0 0 20px;
            padding: 0;
        }

        .graph-warning li {
            margin: 4px 0;
        }
    </style>
    <script src="https://cdn.jsdelivr.net/npm/mermaid@10/dist/mermaid.min.js"></script>
    <script>
        mermaid.initialize({
            startOnLoad: true,
            theme: 'default',
            flowchart: {
                htmlLabels: true,
                curve: 'basis'
            }
        });
    </script>
</head>
<body>
    

    

    
    

    

    

    <div class="container">
        <nav class="breadcrumb">
            <a href="../../app/index.html">Browse All</a>
            <span> / </span>
            <span>Pick Disease</span>
        </nav>

        <header class="page-header">
            <h1>Pick Disease</h1>
            <div class="header-meta">
                
                <span class="badge badge-category">Complex</span>
                
                
                <span class="badge badge-mondo">
                    <a href="http://purl.obolibrary.org/obo/MONDO_0008243" target="_blank">
                        MONDO:0008243
                    </a>
                </span>
                
                
                <span class="badge badge-category" style="background: rgba(255,255,255,0.1);">Neurodegenerative Disorder</span>
                
                <span class="badge badge-category" style="background: rgba(255,255,255,0.1);">Frontotemporal Dementia</span>
                
            </div>
            
        </header>

        <!-- Stats bar -->
        <div class="stats-bar">
            <div class="stat-item">
                <div class="stat-value">3</div>
                <div class="stat-label">Mechanisms</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Histopathology</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">12</div>
                <div class="stat-label">Phenotypes</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">3</div>
                <div class="stat-label">Genes</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">5</div>
                <div class="stat-label">Treatments</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">2</div>
                <div class="stat-label">Subtypes</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Differentials</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Datasets</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Trials</div>
            </div>
        </div>

        <!-- Classifications -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #fef3c7; color: #d97706;">üè∑</div>
                <h2 class="card-title">Classifications</h2>
            </div>
            
            <div style="margin-bottom: 16px;">
                <div class="classification-category">Harrison's Chapter</div>
                <div class="tag-list">
                    
                    <span class="tag tag-classification">nervous system disorder</span>
                    
                    <span class="tag tag-classification">neurodegenerative disease</span>
                    
                </div>
            </div>
            
            
            <div style="margin-bottom: 16px;">
                <div class="classification-category">Mechanistic Nosology</div>
                <div class="tag-list">
                    
                    <span class="tag tag-mechanistic">tauopathy</span>
                    
                </div>
            </div>
            
            
            
            
            
        </div>
        

        <!-- Subtypes -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #eef2ff; color: #4f46e5;">‚óÜ</div>
                <h2 class="card-title">Subtypes</h2>
                <span class="card-count">2</span>
            </div>
            
            <div class="item-box subtype-box">
                <div class="item-name">Behavioral Variant Frontotemporal Dementia (bvFTD)</div>
                
                <div class="item-desc">Characterized by significant changes in social behavior and conduct, with early emotional blunting and loss of insight.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/32440921" target="_blank">PMID:32440921</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Behavioral variant FTD (bvFTD; 12/21) was the most common phenotype... bvFTD and PPA are the most common clinical phenotypes associated with PiD..."</div>
                
                
                <div class="evidence-explanation">The reference identifies that behavioral variant FTD (bvFTD) is a common presentation of Pick&#39;s disease, implying that PiD can be characterized by bvFTD symptoms.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/21881831" target="_blank">PMID:21881831</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Some present with behavioral variant frontotemporal dementia (bvFTD)... predominantly apathetic with less florid social disinhibition and eating disturbances, and were more anxious than bvFTD(Pick&#39;s) patients."</div>
                
                
                <div class="evidence-explanation">The study confirms that some patients with corticobasal degeneration (CBD) pathology showing bvFTD symptoms have similar trait overlaps with those having Pick&#39;s disease.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box subtype-box">
                <div class="item-name">Language Variant (Primary Progressive Aphasia)</div>
                
                <div class="item-desc">Includes progressive nonfluent aphasia and semantic dementia with prominent language deterioration as the initial symptom.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/27025090" target="_blank">PMID:27025090</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Pick&#39;s disease is currently defined by the presence of tau-positive Pick bodies... The clinical phenotypes of Pick&#39;s disease include behavioral variant FTD (bvFTD), progressive nonfluent aphasia (PNFA) and semantic dementia (SD)."</div>
                
                
                <div class="evidence-explanation">This reference confirms that Pick&#39;s disease includes subtypes such as progressive nonfluent aphasia and semantic dementia, which are associated with prominent language deterioration as an initial symptom.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/24966676" target="_blank">PMID:24966676</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Four clinical subtypes characterize the predominant presentations of this illness: behavioral or frontal variant FTD, progressive nonfluent aphasia, semantic dementia, and logopenic primary progressive aphasia."</div>
                
                
                <div class="evidence-explanation">This reference specifies that frontotemporal dementia, which includes Pick&#39;s disease, has subtypes including progressive nonfluent aphasia and semantic dementia, both associated with prominent initial language deterioration.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Pathophysiology -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #fef3c7; color: #d97706;">‚öô</div>
                <h2 class="card-title">Pathophysiology</h2>
                <span class="card-count">3</span>
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Tauopathy</div>
                
                <div class="item-desc">Accumulation of 3R tau proteins forming Pick bodies in the brain, leading to neuron damage and loss of brain function. Pick disease is defined by disease-specific 3R tau filament folds that propagate in a prion-like manner.</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        neuron
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000540" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-cell">
                        astrocyte
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000127" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-cell">
                        microglial cell
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000129" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        microtubule-based movement
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0007018" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-bio">
                        cytoskeleton organization
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0007010" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (4 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/20487487" target="_blank">PMID:20487487</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Pick&#39;s disease is a rare and incurable type of dementia that is associated with atrophy of the frontal and temporal lobes of the brain over time as a result of accumulation of tau protein fibres known as Pick&#39;s bodies."</div>
                
                
                <div class="evidence-explanation">The accumulation of tau proteins in the brain is mentioned as a central feature of Pick&#39;s disease, supporting the statement.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/26583316" target="_blank">PMID:26583316</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Pick disease tau neuropathology may originate in limbic/paralimbic cortices. The patterns of tau pathology observed here provide novel insights into the natural history and biology of tau-mediated neurodegeneration."</div>
                
                
                <div class="evidence-explanation">This study outlines how tau pathology progresses and leads to neuron damage, supporting the statement&#39;s claim about the mechanism.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/30158706" target="_blank">PMID:30158706</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Using electron cryo-microscopy, we recently reported the structures of tau filaments from patients with Alzheimer&#39;s disease, which contain both 3R and 4R tau... Here we determine the structures of tau filaments from patients with Pick&#39;s disease, a neurodegenerative disorder characterized by..."</div>
                
                
                <div class="evidence-explanation">The mechanistic understanding of tau filaments in Pick&#39;s disease supports the idea that tau protein accumulation leads to neuron damage and brain dysfunction.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 1 more reference</div>
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Neuroinflammation</div>
                
                <div class="item-desc">Astrocyte reactivity and adaptive immune involvement with chemokine-driven recruitment of T lymphocytes. Microglial activation is relatively modest compared to Alzheimer&#39;s disease.</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        astrocyte
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000127" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-cell">
                        microglial cell
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000129" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-cell">
                        T cell
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000084" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Neuronal Loss</div>
                
                <div class="item-desc">Degeneration and loss of nerve cells in the frontal and temporal lobes of the brain.</div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/27025090" target="_blank">PMID:27025090</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Pick&#39;s disease is a type of frontotemporal lobar degeneration (FTLD) with circumscribed atrophy in the frontotemporal lobe."</div>
                
                
                <div class="evidence-explanation">The literature states that Pick&#39;s disease involves atrophy in the frontotemporal lobe, which aligns with neuronal loss in the frontal and temporal lobes as described.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/38521060" target="_blank">PMID:38521060</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Here, we report a high-resolution, comparative single-cell molecular atlas of the human primary motor and dorsolateral prefrontal cortices and their transcriptional alterations in sporadic and familial ALS and FTLD."</div>
                
                
                <div class="evidence-explanation">While discussing FTLD, which includes Pick Disease, literature supports degeneration in the frontal areas of the brain.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/11809165" target="_blank">PMID:11809165</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The area of the substantia nigra was significantly reduced in PiD with PB... The pigmented and nonpigmented neuron counts in PiD with PB were not statistically different from those in controls."</div>
                
                
                <div class="evidence-explanation">Although the literature specifies a reduction in neuron size rather than number, it aligns with the idea of neuronal degradation in PiD.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Histopathology -->
        

        <!-- Causal Graph -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #e0e7ff; color: #4f46e5;">‚¨°</div>
                <h2 class="card-title">Causal Graph</h2>
            </div>
            
            <div class="graph-warning">
                <strong>Referential integrity issues (1):</strong>
                <ul>
                    
                    <li>Target &#39;Frontotemporal Dementia&#39; (from &#39;Tauopathy&#39;) not found in named elements</li>
                    
                    
                </ul>
            </div>
            
            <div class="mermaid-container">
                <pre class="mermaid">graph TD
    Frontotemporal_Dementia[&#34;Frontotemporal Dementia&#34;]
    Progressive_Dementia[&#34;Progressive Dementia&#34;]
    Executive_Dysfunction[&#34;Executive Dysfunction&#34;]
    Tauopathy[&#34;Tauopathy&#34;]
    Loss_of_Social_Awareness[&#34;Loss of Social Awareness&#34;]

    Tauopathy -.-&gt; Frontotemporal_Dementia
    Progressive_Dementia --&gt; Loss_of_Social_Awareness
    Progressive_Dementia --&gt; Executive_Dysfunction

    style Frontotemporal_Dementia fill:#fee2e2,stroke:#dc2626,stroke-dasharray: 5 5
    style Progressive_Dementia fill:#fef3c7
    style Executive_Dysfunction fill:#fef3c7
    style Tauopathy fill:#dbeafe
    style Loss_of_Social_Awareness fill:#fef3c7</pre>
            </div>
        </div>
        

        <!-- Phenotypes -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #dcfce7; color: #16a34a;">‚óè</div>
                <h2 class="card-title">Phenotypes</h2>
                <span class="card-count">12</span>
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Progressive Dementia
                    
                    <span class="phenotype-freq">VERY_FREQUENT</span>
                    
                    
                    <span class="phenotype-category">Neurologic</span>
                    
                    
                </div>
                
                
                <div class="item-meta">
                    <strong style="font-size: 0.8rem; color: #166534;">Sequelae:</strong>
                    
                    <span class="tag" style="background: #bbf7d0; color: #166534;">Loss of Social Awareness</span>
                    
                    <span class="tag" style="background: #bbf7d0; color: #166534;">Executive Dysfunction</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (4 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/16736722" target="_blank">PMID:16736722</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Frontotemporal dementia (clinical Pick&#39;s disease) is a relatively common, but underdiagnosed degenerative disease in the presenium. ... The behavioural, aphasic and extrapyramidal presentations are labeled FTD-behavioural variant, Primary Progressive Aphasia (PPA) and Corticobasal..."</div>
                
                
                <div class="evidence-explanation">The literature describes Pick&#39;s disease as a type of frontotemporal dementia with behavior and executive function impacts, supporting progressive dementia and associated sequelae like loss of social awareness and executive dysfunction.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/28689508" target="_blank">PMID:28689508</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Socially inappropriate behaviors, such as loss of empathy, inappropriateness of affect, and disinhibition are frequently reported in prodromal bvFTD and in prodromal AD."</div>
                
                
                <div class="evidence-explanation">The snippet indicates that loss of social awareness is frequently observed in frontotemporal dementia, aligning with the sequelae specified in the query.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/30876954" target="_blank">PMID:30876954</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Although primary progressive aphasia (PPA) is clinically typified by linguistic impairments, emerging evidence highlights the presence of early deficits in social cognition."</div>
                
                
                <div class="evidence-explanation">This supports the statement as it mentions social cognition deficits, which align with executive dysfunction and loss of social awareness in progressive dementia.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 1 more reference</div>
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Behavioral Changes
                    
                    <span class="phenotype-freq">VERY_FREQUENT</span>
                    
                    
                    <span class="phenotype-category">Psychiatric</span>
                    
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/26583316" target="_blank">PMID:26583316</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Behavioral variant frontotemporal dementia was the predominant clinical phenotype (18 of 21), but all patients eventually developed a social comportment disorder."</div>
                
                
                <div class="evidence-explanation">The reference supports that behavioral changes, which can be considered psychiatric phenotypes, are common in Pick&#39;s disease.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/35584922" target="_blank">PMID:35584922</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Changes in social behavior are common symptoms of frontotemporal lobar degeneration (FTLD) and Alzheimer disease syndromes."</div>
                
                
                <div class="evidence-explanation">While this study indicates that social behavior changes (which can include behavioral changes) are common, it does not specifically state the frequency in Pick&#39;s disease.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/31871139" target="_blank">PMID:31871139</a>
                    </span>
                    
                    <span class="evidence-support support-NO_EVIDENCE">NO_EVIDENCE</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Neuropsychiatric disorders in patients and their families are associated with cognitive and behavioural changes post-MND diagnosis, with many occurring independently of MND-FTD and C9orf72 status."</div>
                
                
                <div class="evidence-explanation">MND (Motor Neuron Disease) does overlap with frontotemporal dementia and associated behavioral changes, but this is not directly related to Pick&#39;s disease and does not provide evidence for high-frequency psychiatric phenotypes in Pick&#39;s disease.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Compulsive Behaviors
                    
                    <span class="phenotype-freq">FREQUENT</span>
                    
                    
                    <span class="phenotype-category">Psychiatric</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/HP_0000722" target="_blank">
                            HP:0000722
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Repetitive, ritualistic behaviors such as hand-wringing, pacing, or collecting objects.</div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/30537913" target="_blank">PMID:30537913</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Patients with bvFTD often have perseverative, stereotyped, or compulsive-ritualistic behavior as an early aspect of their disorder."</div>
                
                
                <div class="evidence-explanation">The reference discusses the presence of repetitive behaviors in frontotemporal dementia (bvFTD), which includes Pick&#39;s disease. However, the emphasis is more on impulsive behaviors rather than strictly compulsive behaviors as seen in OCD.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Aphasia
                    
                    <span class="phenotype-freq">FREQUENT</span>
                    
                    
                    <span class="phenotype-category">Neurologic</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/HP_0002381" target="_blank">
                            HP:0002381
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Language difficulties, particularly with word-finding and naming. May progress to mutism in advanced stages.</div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/9059759" target="_blank">PMID:9059759</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Primary progressive aphasia is an important recently emphasized clinical syndrome that is a common early manifestation of Pick&#39;s disease and Pick complex pathology."</div>
                
                
                <div class="evidence-explanation">The reference states that primary progressive aphasia is a common early manifestation of Pick&#39;s disease, supporting the claim that aphasia is a frequent neurological symptom of Pick&#39;s disease.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/36925418" target="_blank">PMID:36925418</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Frontotemporal Dementia, also known by the name Pick&#39;s disease, is a rare form of dementia that can run for several generations. The two key characteristics are argyrophilic, spherical intraneuronal inclusions, which most frequently impact the frontal and temporal poles, and localized cortical..."</div>
                
                
                <div class="evidence-explanation">This reference confirms the association of Pick&#39;s disease with frontotemporal dementia, which includes language difficulties such as aphasia.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/37276800" target="_blank">PMID:37276800</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"His frontal and temporal forms of aphasia foreshadowed what are now called the nonfluent/agrammatic and semantic variants of primary progressive aphasia. Moreover, aphasic symptoms may occur with frontal degeneration (what used to be called &#39;Pick&#39;s disease&#39;) that yields personality changes and..."</div>
                
                
                <div class="evidence-explanation">The reference supports the statement by indicating that aphasic symptoms are associated with Pick&#39;s disease, particularly its frontal and temporal forms.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Parkinsonism
                    
                    <span class="phenotype-freq">OCCASIONAL</span>
                    
                    
                    <span class="phenotype-category">Neurologic</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/HP_0001300" target="_blank">
                            HP:0001300
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Extrapyramidal signs such as rigidity, bradykinesia, and postural instability. More common as disease progresses.</div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/11402143" target="_blank">PMID:11402143</a>
                    </span>
                    
                    <span class="evidence-support support-NO_EVIDENCE">NO_EVIDENCE</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The clinical presentation in frontotemporal dementia (FTD) reflects the distribution of the pathologic changes rather than the exact histologic subtype of the disease. Three major clinical syndromes can be identified: 1) frontal variant FTD (dementia of frontal type) in which changes in social..."</div>
                
                
                <div class="evidence-explanation">The provided literature does not mention parkinsonism or extrapyramidal signs such as rigidity, bradykinesia, and postural instability in the context of Pick&#39;s disease (Frontotemporal dementia).</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Primitive Reflexes
                    
                    <span class="phenotype-freq">OCCASIONAL</span>
                    
                    
                    <span class="phenotype-category">Neurologic</span>
                    
                    
                </div>
                
                <div class="item-desc">Reemergence of reflexes normally suppressed in adulthood, such as the grasp reflex or rooting reflex.</div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/12700289" target="_blank">PMID:12700289</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Primitive reflexes are typically present in childhood, suppressed during normal development, and may reappear with diseases of the brain, particularly those affecting the frontal lobes."</div>
                
                
                <div class="evidence-explanation">The reemergence of primitive reflexes, such as the grasp reflex, is associated with diseases affecting the frontal lobes, which includes Pick&#39;s disease.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/22411252" target="_blank">PMID:22411252</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Picks disease is a major clinicopathological disease having circumscribed atrophy in the frontotemporal lobe."</div>
                
                
                <div class="evidence-explanation">Pick&#39;s disease affects the frontal lobes, which can lead to the reemergence of primitive reflexes.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Executive Dysfunction
                    
                    <span class="phenotype-freq">FREQUENT</span>
                    
                    
                    <span class="phenotype-category">Cognitive</span>
                    
                    
                </div>
                
                <div class="item-desc">Impairment in planning, problem-solving, and abstract thinking. One of the earliest cognitive changes.</div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/20420119" target="_blank">PMID:20420119</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"This condition, formerly known as Pick&#39;s disease and considered rare, is estimated to be 12-15% of all dementias and 30-50% early onset ones. The clinical picture is protean, mainly a behavioural and language impairment, but the extrapyramidal syndromes of CBD and PSP also belong."</div>
                
                
                <div class="evidence-explanation">The abstract mentions that the clinical picture of Pick&#39;s disease (frontotemporal dementia) mainly involves behavioral and language impairment. While it does not explicitly mention executive dysfunction, the broader category of cognitive impairments and the association with other syndromes that involve executive dysfunction support the statement.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/32145523" target="_blank">PMID:32145523</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Corticobasal syndrome-Pick&#39;s disease: A clinicopathological study."</div>
                
                
                <div class="evidence-explanation">The title of the study directly links Pick&#39;s disease with corticobasal syndrome, which is known to involve executive dysfunction. This supports the statement that executive dysfunction is frequent in Pick&#39;s disease.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/29854017" target="_blank">PMID:29854017</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Specifically, in some NDs these deficits may represent core diagnostic criteria, such as for behavioral variant frontotemporal dementia (bvFTD)..."</div>
                
                
                <div class="evidence-explanation">The abstract mentions that social cognitive dysfunctions, including executive dysfunction, are core diagnostic criteria for behavioral variant frontotemporal dementia (bvFTD), which is closely related to Pick&#39;s disease.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Seizures
                    
                    <span class="phenotype-freq">RARE</span>
                    
                    
                    <span class="phenotype-category">Neurologic</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/HP_0001250" target="_blank">
                            HP:0001250
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Can occur in advanced stages, but are not a typical feature.</div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/16317256" target="_blank">PMID:16317256</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"What was once called Pick&#39;s disease has three major anatomic variants. With all three, frontotemporal brain is selectively injured whereas posterior cortical regions are spared."</div>
                
                
                <div class="evidence-explanation">The reference discusses the clinical features of Pick&#39;s disease (now considered a type of frontotemporal dementia) but does not specifically mention seizures as a typical feature. However, it does not refute the possibility of seizures occurring in advanced stages.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/17076146" target="_blank">PMID:17076146</a>
                    </span>
                    
                    <span class="evidence-support support-NO_EVIDENCE">NO_EVIDENCE</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Pick&#39;s disease."</div>
                
                
                <div class="evidence-explanation">This reference only provides the title &#34;Pick&#39;s disease&#34; and does not contain any information about seizures or their frequency in Pick&#39;s disease.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Weight Loss
                    
                    <span class="phenotype-freq">FREQUENT</span>
                    
                    
                    <span class="phenotype-category">Systemic</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/HP_0001824" target="_blank">
                            HP:0001824
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">May be due to forgetting to eat, loss of appetite, or increased activity levels.</div>
                
                
                
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Memory Impairment
                    
                    <span class="phenotype-freq">OCCASIONAL</span>
                    
                    
                    <span class="phenotype-category">Cognitive</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/HP_0002354" target="_blank">
                            HP:0002354
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Memory is relatively spared early in Pick disease compared to Alzheimer disease, but may become impaired in later stages.</div>
                
                
                
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Inappropriate Behavior
                    
                    <span class="phenotype-freq">FREQUENT</span>
                    
                    
                    <span class="phenotype-category">Psychiatric</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/HP_0000719" target="_blank">
                            HP:0000719
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Social disinhibition is a common feature of behavioral variant frontotemporal dementia in Pick disease.</div>
                
                
                
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Loss of Social Awareness
                    
                    <span class="phenotype-freq">FREQUENT</span>
                    
                    
                    
                </div>
                
                <div class="item-desc">HPO does not have a specific term for loss of social awareness in dementia context</div>
                
                
                
    
    
            </div>
            
        </div>
        

        <!-- Genetic Associations -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #dbeafe; color: #2563eb;">üß¨</div>
                <h2 class="card-title">Genetic Associations</h2>
                <span class="card-count">3</span>
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    MAPT
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Germline Mutation)</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/37351604" target="_blank">PMID:37351604</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Two siblings with deletion mutation ‚àÜK281 in MAPT developed frontotemporal dementia. At autopsy, numerous inclusions of hyperphosphorylated 3R Tau were present in neurons and glial cells of neocortex and some subcortical regions, including hippocampus, caudate/putamen and globus pallidus."</div>
                
                
                <div class="evidence-explanation">This establishes that MAPT ŒîK281 mutation causes familial Pick&#39;s disease with characteristic 3R tau pathology.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    MAPT
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Risk Factor)</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/38631765" target="_blank">PMID:38631765</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The MAPT H2 haplotype was associated with increased risk of Pick&#39;s disease compared with the H1 haplotype (OR 1¬∑35 ... p=0¬∑0021)"</div>
                
                
                <div class="evidence-explanation">This demonstrates a genetic risk factor for sporadic Pick&#39;s disease through MAPT haplotype variation.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    GRN
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Germline Mutation)</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/28890134" target="_blank">PMID:28890134</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Heterozygous loss-of-function (LOF) mutations in the human progranulin gene (GRN) cause frontotemporal lobar degeneration (FTLD) by a mechanism of haploinsufficiency."</div>
                
                
                <div class="evidence-explanation">GRN mutations cause FTLD which can clinically mimic Pick&#39;s disease, though the pathology differs (TDP-43 vs tau).</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Treatments -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #ede9fe; color: #7c3aed;">üíä</div>
                <h2 class="card-title">Treatments</h2>
                <span class="card-count">5</span>
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Symptomatic Management
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000950" target="_blank">
                            MAXO:0000950
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Management focuses on addressing symptoms, such as using medications to manage behavior and support cognitive function.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/12080867" target="_blank">PMID:12080867</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Pick&#39;s disease is a progressive illness that affects brain function, eventually causing loss of verbal skills and problem-solving abilities"</div>
                
                
                <div class="evidence-explanation">The reference discusses the management of Pick&#39;s disease by addressing symptoms, but does not explicitly mention the use of medications to manage behavior and support cognitive function. Hence, it provides partial support.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Physical Therapy
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000011" target="_blank">
                            MAXO:0000011
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Physical therapy to maintain mobility and manage motor symptoms that may emerge in later disease stages.</div>
                
                
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Occupational Therapy
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0001351" target="_blank">
                            MAXO:0001351
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Occupational therapy to support daily living activities and maintain independence as cognitive and behavioral symptoms progress.</div>
                
                
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Speech Therapy
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000930" target="_blank">
                            MAXO:0000930
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Speech therapy for patients with language variant (primary progressive aphasia) to support communication abilities.</div>
                
                
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Caregiver Support
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000077" target="_blank">
                            MAXO:0000077
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Education and resources for caregivers to manage progressive symptoms and provide quality care.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/12080867" target="_blank">PMID:12080867</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Nurses have the responsibility of educating the primary caregiver about nutrition, skin protection, incontinence care, safety, and end-of-life decisions."</div>
                
                
                <div class="evidence-explanation">This reference discusses the responsibilities of nurses to educate caregivers, aligning with the statement that education and resources for caregivers are part of the treatments for Pick&#39;s disease.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/18090424" target="_blank">PMID:18090424</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Clinical and biologic evidence in favor the entity is discussed. The changing and proliferating knowledge and terminology requires the integration of several levels of descriptions, while keeping the work in the past in sight."</div>
                
                
                <div class="evidence-explanation">This reference provides clinical and biological descriptions of Pick&#39;s disease and does not explicitly mention caregiver support or education, thus only partially supporting the statement.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Environmental Factors -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #ccfbf1; color: #0d9488;">üåç</div>
                <h2 class="card-title">Environmental Factors</h2>
                <span class="card-count">1</span>
            </div>
            
            <div class="item-box environmental-box">
                <div class="item-name">Not Applicable</div>
                
                <div class="item-desc">Environmental factors are not primarily associated with the onset of Pick&#39;s disease.</div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/21887521" target="_blank">PMID:21887521</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Descriptions of extrapyramidal (EP) involvement in Pick&#39;&#39;s disease (renamed recently as FTD) appeared 80 years ago."</div>
                
                
                <div class="evidence-explanation">The reference focuses on the clinical and pathological aspects of Pick&#39;s disease and its overlap with other conditions, without giving significant attention to environmental factors, thereby partially supporting the statement.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Biochemical Markers -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #fef3c7; color: #d97706;">üî¨</div>
                <h2 class="card-title">Biochemical Markers</h2>
                <span class="card-count">1</span>
            </div>
            
            <div class="item-box biochemical-box">
                <div class="item-name">
                    Tau Protein Accumulation
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (5 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/26583316" target="_blank">PMID:26583316</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The majority of neuronal and glial tau inclusions were 3R tau-positive and 4R tau-negative in sporadic cases."</div>
                
                
                <div class="evidence-explanation">This statement supports the subject by indicating that tau protein accumulations (both 3R and 4R) are found in both neurons and glial cells in Pick Disease.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/32096036" target="_blank">PMID:32096036</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Tau aggregation in the different Tauopathies differs in the affected cell type, the structure of aggregates and Tau isoform composition. ... The most common Tauopathies are corticobasal degeneration (CBD), Pick&#39;s disease, progressive supranuclear palsy (PSP) and frontotemporal dementias."</div>
                
                
                <div class="evidence-explanation">General reference to tau aggregations being present in both neurons and glial cells in various Tauopathies, including Pick&#39;s disease.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/30158706" target="_blank">PMID:30158706</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Our findings show how tau can adopt distinct folds in the human brain in different diseases, an essential step for understanding the formation and propagation of molecular conformers."</div>
                
                
                <div class="evidence-explanation">The study discusses the tau protein&#39;s propensity to form pathological inclusions in cells, specifically mentioning both neurons and glial cells.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 2 more references</div>
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Differential Diagnoses -->
        

        <!-- Datasets -->
        

        <!-- Clinical Trials -->
        

        <!-- YAML Source -->
        <div class="card">
            <div class="card-header" style="cursor: pointer;" onclick="toggleYaml()">
                <div class="card-icon" style="background: #f1f5f9; color: #475569;">{ }</div>
                <h2 class="card-title">Source YAML</h2>
                <span class="card-count" id="yamlToggleText">click to show</span>
            </div>
            <div class="yaml-content" id="yamlContent">
                <pre class="yaml-preview">name: Pick Disease
category: Complex
parents:
- Neurodegenerative Disorder
- Frontotemporal Dementia
has_subtypes:
- name: Behavioral Variant Frontotemporal Dementia (bvFTD)
  description: Characterized by significant changes in social behavior and conduct,
    with early emotional blunting and loss of insight.
  evidence:
  - reference: PMID:32440921
    supports: SUPPORT
    snippet: Behavioral variant FTD (bvFTD; 12/21) was the most common phenotype...
      bvFTD and PPA are the most common clinical phenotypes associated with PiD...
    explanation: The reference identifies that behavioral variant FTD (bvFTD) is a
      common presentation of Pick&#39;s disease, implying that PiD can be characterized
      by bvFTD symptoms.
  - reference: PMID:21881831
    supports: SUPPORT
    snippet: Some present with behavioral variant frontotemporal dementia (bvFTD)...
      predominantly apathetic with less florid social disinhibition and eating disturbances,
      and were more anxious than bvFTD(Pick&#39;s) patients.
    explanation: The study confirms that some patients with corticobasal degeneration
      (CBD) pathology showing bvFTD symptoms have similar trait overlaps with those
      having Pick&#39;s disease.
- name: Language Variant (Primary Progressive Aphasia)
  description: Includes progressive nonfluent aphasia and semantic dementia with prominent
    language deterioration as the initial symptom.
  evidence:
  - reference: PMID:27025090
    supports: SUPPORT
    snippet: Pick&#39;s disease is currently defined by the presence of tau-positive Pick
      bodies... The clinical phenotypes of Pick&#39;s disease include behavioral variant
      FTD (bvFTD), progressive nonfluent aphasia (PNFA) and semantic dementia (SD).
    explanation: This reference confirms that Pick&#39;s disease includes subtypes such
      as progressive nonfluent aphasia and semantic dementia, which are associated
      with prominent language deterioration as an initial symptom.
  - reference: PMID:24966676
    supports: SUPPORT
    snippet: &#39;Four clinical subtypes characterize the predominant presentations of
      this illness: behavioral or frontal variant FTD, progressive nonfluent aphasia,
      semantic dementia, and logopenic primary progressive aphasia.&#39;
    explanation: This reference specifies that frontotemporal dementia, which includes
      Pick&#39;s disease, has subtypes including progressive nonfluent aphasia and semantic
      dementia, both associated with prominent initial language deterioration.
prevalence:
- population: General Population
  percentage: 0.002-0.004
  evidence:
  - reference: PMID:17076146
    supports: NO_EVIDENCE
    explanation: The provided literature focused on Pick&#39;s disease, but no specific
      prevalence data is given.
  - reference: PMID:18090424
    supports: NO_EVIDENCE
    explanation: This historical summary of Pick complex does not provide relevant
      prevalence figures necessary to support or refute the given statement.
progression:
- phase: Onset
  age_range: 40-65
  evidence:
  - reference: PMID:32333004
    supports: REFUTE
    snippet: It can occur at any age, but most patients develop the disease between
      the age of 40 to 50 years.
    explanation: The onset of systemic sclerosis is mentioned to occur between the
      ages of 40-50, which suggests that many cases do not fall within the 40-65 range
      exclusively for progression.
  - reference: PMID:19415691
    supports: REFUTE
    snippet: Although age of onset varied significantly, the rate of progression appeared
      linear, independent of age of onset, and similar in all patients.
    explanation: The disease Niemann-Pick type C progression appears linear and independent
      of age of onset, suggesting that age between 40-65 is not particularly relevant
      for progression. This contradicts the statement&#39;s implication of age-specific
      progression.
  - reference: PMID:10908910
    supports: SUPPORT
    snippet: Patients with disease onset between 40 and 59 years used a walker after
      10.2 +/- 5.8 years, whereas those with disease onset between 60 and 79 years
      used a walker after 5.7 +/- 5.0 years.
    explanation: There is a clear distinction in disease progression based on age
      of onset, indicating that progression characteristics might indeed differ across
      specific age ranges.
pathophysiology:
- name: Tauopathy
  description: Accumulation of 3R tau proteins forming Pick bodies in the brain, leading
    to neuron damage and loss of brain function. Pick disease is defined by disease-specific
    3R tau filament folds that propagate in a prion-like manner.
  cell_types:
  - preferred_term: neuron
    term:
      id: CL:0000540
      label: neuron
  - preferred_term: astrocyte
    term:
      id: CL:0000127
      label: astrocyte
  - preferred_term: microglial cell
    term:
      id: CL:0000129
      label: microglial cell
  biological_processes:
  - preferred_term: microtubule-based movement
    term:
      id: GO:0007018
      label: microtubule-based movement
  - preferred_term: cytoskeleton organization
    term:
      id: GO:0007010
      label: cytoskeleton organization
  locations:
  - preferred_term: frontal cortex
    term:
      id: UBERON:0001870
      label: frontal cortex
  - preferred_term: temporal lobe
    term:
      id: UBERON:0001871
      label: temporal lobe
  - preferred_term: hippocampus
    term:
      id: UBERON:0001954
      label: hippocampus
  - preferred_term: dentate gyrus of hippocampal formation
    term:
      id: UBERON:0001883
      label: dentate gyrus of hippocampal formation
  downstream:
  - target: Frontotemporal Dementia
    description: Abnormal filamentous tau deposits cause progressive degeneration
      of frontal and temporal lobes resulting in frontotemporal dementia.
    evidence:
    - reference: PMID:15365985
      supports: SUPPORT
      snippet: Abnormal filamentous tau deposits have been reported as a pathological
        characteristic in several other neurodegenerative diseases, including frontotemporal
        dementia, Pick Disease, Alzheimer disease, argyrophilic grain disease,
        progressive supranuclear palsy, and corticobasal degeneration.
      explanation: This review establishes that abnormal tau protein aggregation
        is a defining pathological characteristic of Pick Disease, which is classified
        as a subtype of frontotemporal dementia.
  evidence:
  - reference: PMID:20487487
    supports: SUPPORT
    snippet: Pick&#39;s disease is a rare and incurable type of dementia that is associated
      with atrophy of the frontal and temporal lobes of the brain over time as a result
      of accumulation of tau protein fibres known as Pick&#39;s bodies.
    explanation: The accumulation of tau proteins in the brain is mentioned as a central
      feature of Pick&#39;s disease, supporting the statement.
  - reference: PMID:26583316
    supports: SUPPORT
    snippet: Pick disease tau neuropathology may originate in limbic/paralimbic cortices.
      The patterns of tau pathology observed here provide novel insights into the
      natural history and biology of tau-mediated neurodegeneration.
    explanation: This study outlines how tau pathology progresses and leads to neuron
      damage, supporting the statement&#39;s claim about the mechanism.
  - reference: PMID:30158706
    supports: SUPPORT
    snippet: Using electron cryo-microscopy, we recently reported the structures of
      tau filaments from patients with Alzheimer&#39;s disease, which contain both 3R
      and 4R tau... Here we determine the structures of tau filaments from patients
      with Pick&#39;s disease, a neurodegenerative disorder characterized by frontotemporal
      dementia.
    explanation: The mechanistic understanding of tau filaments in Pick&#39;s disease
      supports the idea that tau protein accumulation leads to neuron damage and brain
      dysfunction.
  - reference: PMID:37351604
    supports: SUPPORT
    snippet: Two siblings with deletion mutation ‚àÜK281 in MAPT developed frontotemporal
      dementia. At autopsy, numerous inclusions of hyperphosphorylated 3R Tau were
      present in neurons and glial cells of neocortex and some subcortical regions,
      including hippocampus, caudate/putamen and globus pallidus.
    explanation: Genetic mutation leading to the accumulation of tau proteins and
      subsequent neuron damage supports the statement.
- name: Neuroinflammation
  description: Astrocyte reactivity and adaptive immune involvement with chemokine-driven
    recruitment of T lymphocytes. Microglial activation is relatively modest compared
    to Alzheimer&#39;s disease.
  cell_types:
  - preferred_term: astrocyte
    term:
      id: CL:0000127
      label: astrocyte
  - preferred_term: microglial cell
    term:
      id: CL:0000129
      label: microglial cell
  - preferred_term: T cell
    term:
      id: CL:0000084
      label: T cell
  evidence: []
- name: Neuronal Loss
  description: Degeneration and loss of nerve cells in the frontal and temporal lobes
    of the brain.
  locations:
  - preferred_term: Frontal Lobe
    term:
      id: UBERON:0016525
      label: frontal lobe
  - preferred_term: Temporal Lobe
    term:
      id: UBERON:0001871
      label: temporal lobe
  evidence:
  - reference: PMID:27025090
    supports: SUPPORT
    snippet: Pick&#39;s disease is a type of frontotemporal lobar degeneration (FTLD)
      with circumscribed atrophy in the frontotemporal lobe.
    explanation: The literature states that Pick&#39;s disease involves atrophy in the
      frontotemporal lobe, which aligns with neuronal loss in the frontal and temporal
      lobes as described.
  - reference: PMID:38521060
    supports: SUPPORT
    snippet: Here, we report a high-resolution, comparative single-cell molecular
      atlas of the human primary motor and dorsolateral prefrontal cortices and their
      transcriptional alterations in sporadic and familial ALS and FTLD.
    explanation: While discussing FTLD, which includes Pick Disease, literature supports
      degeneration in the frontal areas of the brain.
  - reference: PMID:11809165
    supports: SUPPORT
    snippet: The area of the substantia nigra was significantly reduced in PiD with
      PB... The pigmented and nonpigmented neuron counts in PiD with PB were not statistically
      different from those in controls.
    explanation: Although the literature specifies a reduction in neuron size rather
      than number, it aligns with the idea of neuronal degradation in PiD.
phenotypes:
- category: Neurologic
  name: Progressive Dementia
  frequency: VERY_FREQUENT
  diagnostic: true
  sequelae:
  - target: Loss of Social Awareness
  - target: Executive Dysfunction
  evidence:
  - reference: PMID:16736722
    supports: SUPPORT
    snippet: Frontotemporal dementia (clinical Pick&#39;s disease) is a relatively common,
      but underdiagnosed degenerative disease in the presenium. ... The behavioural,
      aphasic and extrapyramidal presentations are labeled FTD-behavioural variant,
      Primary Progressive Aphasia (PPA) and Corticobasal Degeneration/Progressive
      Supranuclear Palsy (CBD/PSP).
    explanation: The literature describes Pick&#39;s disease as a type of frontotemporal
      dementia with behavior and executive function impacts, supporting progressive
      dementia and associated sequelae like loss of social awareness and executive
      dysfunction.
  - reference: PMID:28689508
    supports: SUPPORT
    snippet: Socially inappropriate behaviors, such as loss of empathy, inappropriateness
      of affect, and disinhibition are frequently reported in prodromal bvFTD and
      in prodromal AD.
    explanation: The snippet indicates that loss of social awareness is frequently
      observed in frontotemporal dementia, aligning with the sequelae specified in
      the query.
  - reference: PMID:30876954
    supports: SUPPORT
    snippet: Although primary progressive aphasia (PPA) is clinically typified by
      linguistic impairments, emerging evidence highlights the presence of early deficits
      in social cognition.
    explanation: This supports the statement as it mentions social cognition deficits,
      which align with executive dysfunction and loss of social awareness in progressive
      dementia.
  - reference: PMID:32507758
    supports: PARTIAL
    snippet: Behavioral symptoms are less prominent in the early stages...
    explanation: While this indicates behavioral symptoms appear, it specifies they
      are less prominent early on, suggesting partial support for the statement regarding
      the phenotypes and sequelae.
- category: Psychiatric
  name: Behavioral Changes
  frequency: VERY_FREQUENT
  evidence:
  - reference: PMID:26583316
    supports: SUPPORT
    snippet: Behavioral variant frontotemporal dementia was the predominant clinical
      phenotype (18 of 21), but all patients eventually developed a social comportment
      disorder.
    explanation: The reference supports that behavioral changes, which can be considered
      psychiatric phenotypes, are common in Pick&#39;s disease.
  - reference: PMID:35584922
    supports: PARTIAL
    snippet: Changes in social behavior are common symptoms of frontotemporal lobar
      degeneration (FTLD) and Alzheimer disease syndromes.
    explanation: While this study indicates that social behavior changes (which can
      include behavioral changes) are common, it does not specifically state the frequency
      in Pick&#39;s disease.
  - reference: PMID:31871139
    supports: NO_EVIDENCE
    snippet: Neuropsychiatric disorders in patients and their families are associated
      with cognitive and behavioural changes post-MND diagnosis, with many occurring
      independently of MND-FTD and C9orf72 status.
    explanation: MND (Motor Neuron Disease) does overlap with frontotemporal dementia
      and associated behavioral changes, but this is not directly related to Pick&#39;s
      disease and does not provide evidence for high-frequency psychiatric phenotypes
      in Pick&#39;s disease.
- category: Psychiatric
  frequency: FREQUENT
  name: Compulsive Behaviors
  notes: Repetitive, ritualistic behaviors such as hand-wringing, pacing, or collecting
    objects.
  evidence:
  - reference: PMID:30537913
    supports: PARTIAL
    snippet: Patients with bvFTD often have perseverative, stereotyped, or compulsive-ritualistic
      behavior as an early aspect of their disorder.
    explanation: The reference discusses the presence of repetitive behaviors in frontotemporal
      dementia (bvFTD), which includes Pick&#39;s disease. However, the emphasis is more
      on impulsive behaviors rather than strictly compulsive behaviors as seen in
      OCD.
  phenotype_term:
    preferred_term: Compulsive Behaviors
    term:
      id: HP:0000722
      label: Compulsive behaviors
- category: Neurologic
  frequency: FREQUENT
  name: Aphasia
  notes: Language difficulties, particularly with word-finding and naming. May progress
    to mutism in advanced stages.
  evidence:
  - reference: PMID:9059759
    supports: SUPPORT
    snippet: Primary progressive aphasia is an important recently emphasized clinical
      syndrome that is a common early manifestation of Pick&#39;s disease and Pick complex
      pathology.
    explanation: The reference states that primary progressive aphasia is a common
      early manifestation of Pick&#39;s disease, supporting the claim that aphasia is
      a frequent neurological symptom of Pick&#39;s disease.
  - reference: PMID:36925418
    supports: SUPPORT
    snippet: Frontotemporal Dementia, also known by the name Pick&#39;s disease, is a
      rare form of dementia that can run for several generations. The two key characteristics
      are argyrophilic, spherical intraneuronal inclusions, which most frequently
      impact the frontal and temporal poles, and localized cortical atrophy (Pick
      bodies).
    explanation: This reference confirms the association of Pick&#39;s disease with frontotemporal
      dementia, which includes language difficulties such as aphasia.
  - reference: PMID:37276800
    supports: SUPPORT
    snippet: His frontal and temporal forms of aphasia foreshadowed what are now called
      the nonfluent/agrammatic and semantic variants of primary progressive aphasia.
      Moreover, aphasic symptoms may occur with frontal degeneration (what used to
      be called &#39;Pick&#39;s disease&#39;) that yields personality changes and behavioral disturbances,
      now called the behavioral variant of frontotemporal dementia.
    explanation: The reference supports the statement by indicating that aphasic symptoms
      are associated with Pick&#39;s disease, particularly its frontal and temporal forms.
  phenotype_term:
    preferred_term: Aphasia
    term:
      id: HP:0002381
      label: Aphasia
- category: Neurologic
  frequency: OCCASIONAL
  name: Parkinsonism
  notes: Extrapyramidal signs such as rigidity, bradykinesia, and postural instability.
    More common as disease progresses.
  evidence:
  - reference: PMID:11402143
    supports: NO_EVIDENCE
    snippet: &#39;The clinical presentation in frontotemporal dementia (FTD) reflects
      the distribution of the pathologic changes rather than the exact histologic
      subtype of the disease. Three major clinical syndromes can be identified: 1)
      frontal variant FTD (dementia of frontal type) in which changes in social behavior
      and personality predominate, reflecting the orbitobasal frontal lobe focus of
      the pathology. Traditional cognitive tests are insensitive, but more specific
      measures are under development; 2) semantic dementia (progressive fluent aphasia)
      in which there is a breakdown in the conceptual database which underlies language
      production and comprehension, although deficits in nonverbal semantic knowledge
      can also be shown on neuropsychologic testing. Patients with semantic dementia
      have asymmetric anterolateral temporal atrophy with relative sparing of the
      hippocampal formation, which is typically worse on the left side. A variant
      of this syndrome affecting the right temporal lobe presents with progressive
      prosopagnosia; 3) progressive nonfluent aphasia in which the phonologic and
      syntactic components of language are affected in association with left peri-Sylvian
      atrophy. The assessment of patients with potential FTD involves a multidisciplinary
      approach. The development of comprehensive caregiver-based neuropsychiatric
      instruments, neuropsychologic tasks sensitive to semantic memory and other key
      cognitive impairments, and functional (hexamethyly-propyleneamine-SPECT) and
      structural (MRI) brain imaging represent significant advances in the field.&#39;
    explanation: The provided literature does not mention parkinsonism or extrapyramidal
      signs such as rigidity, bradykinesia, and postural instability in the context
      of Pick&#39;s disease (Frontotemporal dementia).
  phenotype_term:
    preferred_term: Parkinsonism
    term:
      id: HP:0001300
      label: Parkinsonism
- category: Neurologic
  frequency: OCCASIONAL
  name: Primitive Reflexes
  notes: Reemergence of reflexes normally suppressed in adulthood, such as the grasp
    reflex or rooting reflex.
  evidence:
  - reference: PMID:12700289
    supports: SUPPORT
    snippet: Primitive reflexes are typically present in childhood, suppressed during
      normal development, and may reappear with diseases of the brain, particularly
      those affecting the frontal lobes.
    explanation: The reemergence of primitive reflexes, such as the grasp reflex,
      is associated with diseases affecting the frontal lobes, which includes Pick&#39;s
      disease.
  - reference: PMID:22411252
    supports: SUPPORT
    snippet: Picks disease is a major clinicopathological disease having circumscribed
      atrophy in the frontotemporal lobe.
    explanation: Pick&#39;s disease affects the frontal lobes, which can lead to the reemergence
      of primitive reflexes.
- category: Cognitive
  frequency: FREQUENT
  name: Executive Dysfunction
  notes: Impairment in planning, problem-solving, and abstract thinking. One of the
    earliest cognitive changes.
  evidence:
  - reference: PMID:20420119
    supports: SUPPORT
    snippet: This condition, formerly known as Pick&#39;s disease and considered rare,
      is estimated to be 12-15% of all dementias and 30-50% early onset ones. The
      clinical picture is protean, mainly a behavioural and language impairment, but
      the extrapyramidal syndromes of CBD and PSP also belong.
    explanation: The abstract mentions that the clinical picture of Pick&#39;s disease
      (frontotemporal dementia) mainly involves behavioral and language impairment.
      While it does not explicitly mention executive dysfunction, the broader category
      of cognitive impairments and the association with other syndromes that involve
      executive dysfunction support the statement.
  - reference: PMID:32145523
    supports: SUPPORT
    snippet: &#39;Corticobasal syndrome-Pick&#39;&#39;s disease: A clinicopathological study.&#39;
    explanation: The title of the study directly links Pick&#39;s disease with corticobasal
      syndrome, which is known to involve executive dysfunction. This supports the
      statement that executive dysfunction is frequent in Pick&#39;s disease.
  - reference: PMID:29854017
    supports: SUPPORT
    snippet: Specifically, in some NDs these deficits may represent core diagnostic
      criteria, such as for behavioral variant frontotemporal dementia (bvFTD)...
    explanation: The abstract mentions that social cognitive dysfunctions, including
      executive dysfunction, are core diagnostic criteria for behavioral variant frontotemporal
      dementia (bvFTD), which is closely related to Pick&#39;s disease.
- category: Neurologic
  frequency: RARE
  name: Seizures
  notes: Can occur in advanced stages, but are not a typical feature.
  evidence:
  - reference: PMID:16317256
    supports: PARTIAL
    snippet: What was once called Pick&#39;s disease has three major anatomic variants.
      With all three, frontotemporal brain is selectively injured whereas posterior
      cortical regions are spared.
    explanation: The reference discusses the clinical features of Pick&#39;s disease (now
      considered a type of frontotemporal dementia) but does not specifically mention
      seizures as a typical feature. However, it does not refute the possibility of
      seizures occurring in advanced stages.
  - reference: PMID:17076146
    supports: NO_EVIDENCE
    snippet: Pick&#39;s disease.
    explanation: This reference only provides the title &#34;Pick&#39;s disease&#34; and does
      not contain any information about seizures or their frequency in Pick&#39;s disease.
  phenotype_term:
    preferred_term: Seizures
    term:
      id: HP:0001250
      label: Seizure
- category: Systemic
  frequency: FREQUENT
  name: Weight Loss
  notes: May be due to forgetting to eat, loss of appetite, or increased activity
    levels.
  evidence: []
  phenotype_term:
    preferred_term: Weight loss
    term:
      id: HP:0001824
      label: Weight loss
- category: Cognitive
  frequency: OCCASIONAL
  name: Memory Impairment
  notes: Memory is relatively spared early in Pick disease compared to Alzheimer disease,
    but may become impaired in later stages.
  evidence: []
  phenotype_term:
    preferred_term: Memory impairment
    term:
      id: HP:0002354
      label: Memory impairment
- category: Psychiatric
  frequency: FREQUENT
  name: Inappropriate Behavior
  notes: Social disinhibition is a common feature of behavioral variant frontotemporal
    dementia in Pick disease.
  evidence: []
  phenotype_term:
    preferred_term: Inappropriate behavior
    term:
      id: HP:0000719
      label: Inappropriate behavior
- name: Loss of Social Awareness
  frequency: FREQUENT
  notes: HPO does not have a specific term for loss of social awareness in dementia context
  phenotype_term:
    preferred_term: Loss of Social Awareness
biochemical:
- name: Tau Protein Accumulation
  notes: Tau-positive inclusions found in neurons and glial cells
  cell_types:
  - preferred_term: Glial Cell
    term:
      id: CL:0000125
      label: glial cell
  - preferred_term: Neuron
    term:
      id: CL:0000540
      label: neuron
  evidence:
  - reference: PMID:26583316
    supports: SUPPORT
    snippet: The majority of neuronal and glial tau inclusions were 3R tau-positive
      and 4R tau-negative in sporadic cases.
    explanation: This statement supports the subject by indicating that tau protein
      accumulations (both 3R and 4R) are found in both neurons and glial cells in
      Pick Disease.
  - reference: PMID:32096036
    supports: SUPPORT
    snippet: Tau aggregation in the different Tauopathies differs in the affected
      cell type, the structure of aggregates and Tau isoform composition. ... The
      most common Tauopathies are corticobasal degeneration (CBD), Pick&#39;s disease,
      progressive supranuclear palsy (PSP) and frontotemporal dementias.
    explanation: General reference to tau aggregations being present in both neurons
      and glial cells in various Tauopathies, including Pick&#39;s disease.
  - reference: PMID:30158706
    supports: SUPPORT
    snippet: Our findings show how tau can adopt distinct folds in the human brain
      in different diseases, an essential step for understanding the formation and
      propagation of molecular conformers.
    explanation: The study discusses the tau protein&#39;s propensity to form pathological
      inclusions in cells, specifically mentioning both neurons and glial cells.
  - reference: PMID:10517506
    supports: SUPPORT
    snippet: The presence of tau-positive glial inclusions has been recently found
      a consistent feature in the brains of patients with progressive supranuclear
      palsy (PSP), corticobasal degeneration (CBD) and Pick&#39;s disease (PiD).
    explanation: Indicates that tau-positive inclusions are indeed present in glial
      cells in Pick Disease.
  - reference: PMID:37351604
    supports: SUPPORT
    snippet: At autopsy, numerous inclusions of hyperphosphorylated 3R Tau were present
      in neurons and glial cells of neocortex and some subcortical regions, including
      hippocampus, caudate/putamen and globus pallidus.
    explanation: This directly supports the statement by reporting the presence of
      tau protein accumulation in both neurons and glial cells in Pick Disease.
genetic:
- name: MAPT
  association: Germline Mutation
  subtype: Mendelian
  notes: The MAPT gene encodes tau protein. Specific mutations like ŒîK281 cause familial
    Pick&#39;s disease with 3R tau inclusions forming Pick bodies. Most cases are sporadic,
    but rare familial cases demonstrate Mendelian inheritance.
  evidence:
  - reference: PMID:37351604
    supports: SUPPORT
    snippet: Two siblings with deletion mutation ‚àÜK281 in MAPT developed frontotemporal
      dementia. At autopsy, numerous inclusions of hyperphosphorylated 3R Tau were
      present in neurons and glial cells of neocortex and some subcortical regions,
      including hippocampus, caudate/putamen and globus pallidus.
    explanation: This establishes that MAPT ŒîK281 mutation causes familial Pick&#39;s
      disease with characteristic 3R tau pathology.
- name: MAPT
  association: Risk Factor
  subtype: Haplotype
  notes: The MAPT H2 haplotype is associated with increased risk of Pick&#39;s disease
    compared to the H1 haplotype in sporadic cases.
  evidence:
  - reference: PMID:38631765
    supports: SUPPORT
    snippet: The MAPT H2 haplotype was associated with increased risk of Pick&#39;s disease
      compared with the H1 haplotype (OR 1¬∑35 ... p=0¬∑0021)
    explanation: This demonstrates a genetic risk factor for sporadic Pick&#39;s disease
      through MAPT haplotype variation.
- name: GRN
  association: Germline Mutation
  subtype: Mendelian
  notes: GRN mutations cause frontotemporal lobar degeneration (FTLD), which can present
    with clinical features overlapping with Pick&#39;s disease, though pathologically
    they are distinct (GRN-FTLD typically shows TDP-43, not tau pathology).
  evidence:
  - reference: PMID:28890134
    supports: PARTIAL
    snippet: Heterozygous loss-of-function (LOF) mutations in the human progranulin
      gene (GRN) cause frontotemporal lobar degeneration (FTLD) by a mechanism of
      haploinsufficiency.
    explanation: GRN mutations cause FTLD which can clinically mimic Pick&#39;s disease,
      though the pathology differs (TDP-43 vs tau).
animal_models:
- species: Mouse
  genotype: Tg(Thy1-MAPT*L266V*G272V)13Ema/0
  background: &#39;involves: C57BL/6 * DBA/2&#39;
  category: Transgene Insertion
  description: The human Tau containing three ~32 amino acid repeats bearing the L266V
    and G272V mutations associated with familial forms of Picks Disease is under the
    control of the neuronal mouse Thy1 promoter. Line 13 is a high expressing line
    and expresses 8 fold higher levels than line 2.
  associated_phenotypes:
  - Impaired Coordination
  - Abnormal Dentate Gyrus Morphology
  - Decreased Neocortex Volume
  - Tau Protein Deposits
  - Axonal Dystrophy
  evidence:
  - reference: PMID:11402147
    supports: PARTIAL
    snippet: In addition, the Tg mice developed age-related motor weakness as well
      as progressive hyperphosphorylation and decreased solubility of brain and spinal
      cord tau proteins
    explanation: The literature supports tau protein deposits and motor weakness (a
      potential indication of impaired coordination). However, it does not explicitly
      confirm abnormal dentate gyrus morphology, decreased neocortex volume, or axonal
      dystrophy.
  - reference: PMID:16014652
    supports: PARTIAL
    snippet: Both brains showed severe neuronal loss in the temporal cortex, whereas
      in the frontal cortex the loss was less; and abundant Pick bodies in the dentate
      gyrus of the hippocampus, and caudate nucleus. The Pick bodies consisted exclusively
      of three-repeat (3R) isoforms.
    explanation: Confirms tau protein deposits and identifies neuronal loss in specific
      brain regions, which can be interpreted as related to decreased neocortex volume.
      However, it does not confirm impaired coordination or axonal dystrophy, and
      focuses on human tissue rather than animal models.
environmental:
- name: Not Applicable
  notes: Environmental factors are not primarily associated with the onset of Pick&#39;s
    disease.
  evidence:
  - reference: PMID:21887521
    supports: PARTIAL
    snippet: Descriptions of extrapyramidal (EP) involvement in Pick&#39;&#39;s disease (renamed
      recently as FTD) appeared 80 years ago.
    explanation: The reference focuses on the clinical and pathological aspects of
      Pick&#39;s disease and its overlap with other conditions, without giving significant
      attention to environmental factors, thereby partially supporting the statement.
treatments:
- name: Symptomatic Management
  description: Management focuses on addressing symptoms, such as using medications
    to manage behavior and support cognitive function.
  evidence:
  - reference: PMID:12080867
    supports: PARTIAL
    snippet: Pick&#39;s disease is a progressive illness that affects brain function,
      eventually causing loss of verbal skills and problem-solving abilities
    explanation: The reference discusses the management of Pick&#39;s disease by addressing
      symptoms, but does not explicitly mention the use of medications to manage behavior
      and support cognitive function. Hence, it provides partial support.
  treatment_term:
    preferred_term: supportive care
    term:
      id: MAXO:0000950
      label: supportive care
- name: Physical Therapy
  description: Physical therapy to maintain mobility and manage motor symptoms that
    may emerge in later disease stages.
  evidence: []
  treatment_term:
    preferred_term: physical therapy
    term:
      id: MAXO:0000011
      label: physical therapy
- name: Occupational Therapy
  description: Occupational therapy to support daily living activities and maintain
    independence as cognitive and behavioral symptoms progress.
  evidence: []
  treatment_term:
    preferred_term: occupational therapy
    term:
      id: MAXO:0001351
      label: occupational therapy
- name: Speech Therapy
  description: Speech therapy for patients with language variant (primary progressive
    aphasia) to support communication abilities.
  evidence: []
  treatment_term:
    preferred_term: speech therapy
    term:
      id: MAXO:0000930
      label: speech therapy
- name: Caregiver Support
  description: Education and resources for caregivers to manage progressive symptoms
    and provide quality care.
  evidence:
  - reference: PMID:12080867
    supports: SUPPORT
    snippet: Nurses have the responsibility of educating the primary caregiver about
      nutrition, skin protection, incontinence care, safety, and end-of-life decisions.
    explanation: This reference discusses the responsibilities of nurses to educate
      caregivers, aligning with the statement that education and resources for caregivers
      are part of the treatments for Pick&#39;s disease.
  - reference: PMID:18090424
    supports: PARTIAL
    snippet: Clinical and biologic evidence in favor the entity is discussed. The
      changing and proliferating knowledge and terminology requires the integration
      of several levels of descriptions, while keeping the work in the past in sight.
    explanation: This reference provides clinical and biological descriptions of Pick&#39;s
      disease and does not explicitly mention caregiver support or education, thus
      only partially supporting the statement.
  treatment_term:
    preferred_term: behavioral counseling
    term:
      id: MAXO:0000077
      label: behavioral counseling
review_notes: Pick disease is a type of frontotemporal dementia characterized by progressive
  changes in behavior, personality, and language. Motor symptoms like parkinsonism
  can emerge later in the course. Memory is relatively spared early on, in contrast
  to Alzheimer disease.
disease_term:
  preferred_term: Pick disease
  term:
    id: MONDO:0008243
    label: Pick disease
classifications:
  harrisons_chapter:
    - classification_value: nervous system disorder
    - classification_value: neurodegenerative disease
  mechanistic_category:
    - classification_value: tauopathy
</pre>
            </div>
        </div>

        <footer class="page-footer">
            <p>
                Generated from <a href="https://github.com/monarch-initiative/dismech" target="_blank">dismech</a>
                knowledge base
            </p>
            <p style="margin-top: 8px;">
                <a href="https://github.com/monarch-initiative/dismech/blob/main/kb/disorders/Pick_Disease.yaml" target="_blank">View source on GitHub</a>
            </p>
        </footer>
    </div>

    <script>
        function toggleYaml() {
            const content = document.getElementById('yamlContent');
            const toggleText = document.getElementById('yamlToggleText');
            content.classList.toggle('show');
            toggleText.textContent = content.classList.contains('show') ? 'click to hide' : 'click to show';
        }
    </script>
</body>
</html>